Molecular Formula | C27H34N6O5 |
Molar Mass | 522.6 |
Storage Condition | 2-8°C(protect from light) |
Use | L-765314 is an effective and selective antagonist of α1b adrenergic receptor (α1b adrenergic receptor), and its Ki values in rats and humans are 5.4 nM and 2.0 nM respectively. |
In vitro study | L-765314 exhibits two displacement sites. The high-affinity site accounts for approximately 25% of binding (IC 50 ) 1.90 nM and represents binding to the R1b sites. The low-affinity site accounts for the residual 75% of binding (IC 50 ) 790 nM and represents binding to the R1a sites. |
In vivo study | The results of plasma assayed by liquid chromatograph/mass spectrometer (LCMS) show that the mean C max of L-765314 (A322312) is 1.05 μM and the t 1/2 is 0.5 h. L-765314 shows weak potency for inhibiting the pressor response to either phenylephrine or A-61603 (AD 25 >3 mg/kg for each). On the basis of the inhibition of pressor responses to the R1a subtype selective agonist A-61603, L-765314 appears to be selective versus the R1a receptor up to a dose of 0.3 mg/kg. The results of hypotensive potency in rats show that both L-765314 and terazosin tend to decrease heart rate (about 25 bpm at 1 mg/kg iv). |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 1.914 ml | 9.568 ml | 19.135 ml |
5 mM | 0.383 ml | 1.914 ml | 3.827 ml |
10 mM | 0.191 ml | 0.957 ml | 1.914 ml |
5 mM | 0.038 ml | 0.191 ml | 0.383 ml |
biological activity | L-765314 is a potent and selective antagonist of α1b adrenergic receptor, its Ki values in rats and humans were 5.4 nM and 2.0 nM, respectively. |
Target | Ki: 5.4±0.6 nM (rat α1b receptor), 2.0±0.66 nM (human α1b receptor), 50±8 nM (rat α1d receptor), 34±6 nM (human α1d receptor), 500±20 nM (rat α1b receptor), 420±62 nM (human α1b receptor). |